newsfilter
← Latest News
GlobeNewswire·

CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones

Data from Single Ascending Dose (SAD) portion of Phase 1 study of CMP-CPS-001 for the treatment of urea cycle disorders (UCDs) demonstrates favorable safety resultsCompleted dosing in the first two Multiple Ascending